breast cancer - Nursing Case Study

Pathophysiology

• Primary mechanism: Genetic mutations in oncogenes and tumor suppressor genes, like BRCA1/BRCA2, lead to uncontrolled cell proliferation by disrupting normal cell cycle regulation and apoptosis pathways.

• Secondary mechanism: Hormonal influences, particularly estrogen and progesterone, promote tumor growth by binding to receptors on breast cancer cells, enhancing their proliferation and survival.

• Key complication: Metastasis occurs when cancer cells invade surrounding tissues and enter the bloodstream or lymphatic system, spreading to distant organs such as bones, lungs, liver, and brain, which significantly worsens prognosis and complicates treatment.

Patient Profile

Demographics:

58-year-old female, retired chemical engineer

History:

• Key past medical history: Diagnosed with stage IV breast cancer two years ago, metastasis to liver and bones, history of hypertension and type 2 diabetes

• Current medications: Doxorubicin, Cyclophosphamide, Metformin, Lisinopril, Insulin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and difficulty breathing

• Key symptoms: Persistent cough, jaundice, severe fatigue, weight loss, bone pain

• Vital signs: Blood pressure 86/54 mmHg, heart rate 122 bpm, respiratory rate 28 breaths per minute, temperature 101.3°F, oxygen saturation 88% on room air

Section 1

As the medical team responds to the patient's severe abdominal pain and respiratory distress, a comprehensive initial assessment is performed to gather critical data guiding the immediate management plan. The patient is visibly jaundiced, with scleral icterus and a distended abdomen suggestive of ascites. On auscultation, diminished breath sounds are noted bilaterally, with crackles at the lung bases, indicating potential pleural effusion and pulmonary involvement. Palpation reveals hepatomegaly and significant tenderness in the right upper quadrant, consistent with liver metastasis exacerbation. The patient's neurological status is also concerning; she appears lethargic and exhibits confusion, raising the suspicion of hepatic encephalopathy due to liver failure.

Laboratory tests reveal further alarming results: elevated liver enzymes with an AST of 130 U/L and ALT of 145 U/L, total bilirubin of 6.8 mg/dL, and an INR of 2.1, indicating coagulopathy. A complete blood count shows anemia with a hemoglobin level of 8.5 g/dL and thrombocytopenia with platelets at 75,000/uL, suggesting bone marrow involvement or chemotherapy-induced myelosuppression. Renal function tests are also impaired, with a serum creatinine of 2.3 mg/dL, raising concerns about acute kidney injury secondary to tumor lysis syndrome or nephrotoxic effects of chemotherapy.

These findings necessitate immediate intervention focusing on stabilizing the patient's hemodynamic status and addressing her respiratory compromise. Oxygen therapy is initiated, and fluid resuscitation is carefully managed to avoid exacerbating potential pulmonary edema. Given the complexity of her condition, the interdisciplinary team must consider the risk-benefit ratio of continuing chemotherapy in the context of her deteriorating liver function and potential need for palliative care measures. As the team deliberates on the next steps, including potential paracentesis and adjustments to her medication regimen, they remain vigilant for any new complications that may arise, further complicating her already precarious clinical picture.

Section 2

As the medical team continues to monitor the patient closely, new diagnostic imaging results reveal additional complications that necessitate immediate attention. A CT scan of the abdomen confirms extensive metastatic involvement of the liver, with multiple lesions causing significant hepatic congestion. The scan also identifies a moderate amount of ascites and a new finding of splenomegaly, which may be contributing to the patient's pancytopenia. Furthermore, a CT of the chest highlights bilateral pleural effusions, more pronounced on the right, along with signs of early pulmonary edema, likely secondary to both fluid overload and compromised cardiac output from hepatic dysfunction.

In response to these findings, the team decides to perform a therapeutic thoracentesis to alleviate the patient's respiratory distress and improve oxygenation. The procedure is conducted with caution, considering the patient's coagulopathy, and yields 800 mL of serous fluid from the right pleural space. Post-procedure, the patient's oxygen saturation improves marginally, stabilizing at 92% on 4L nasal cannula, although she continues to exhibit tachypnea with a respiratory rate of 28 breaths per minute. Meanwhile, ongoing laboratory monitoring shows a slight increase in serum lactate to 3.5 mmol/L, indicating a worsening metabolic state, possibly due to a combination of hypoperfusion and septic physiology.

The clinical picture is further complicated by the emergence of new symptoms suggestive of systemic infection. The patient develops a fever of 38.5°C (101.3°F) and her leukocyte count, previously within normal limits, rises to 14,000/uL with a left shift, prompting the initiation of broad-spectrum intravenous antibiotics. Blood cultures are drawn to identify any potential pathogens, as the team remains vigilant for signs of sepsis. This development calls for a delicate balance between aggressive treatment to address the infection and supportive care to manage the underlying malignancy and organ dysfunction, underscoring the complexity of her condition and necessitating continuous reassessment and adaptation of the treatment plan.

Section 3

Change in Patient Status:

Despite the aggressive interventions, the patient's condition takes a critical turn overnight. Nurses monitoring her observe a sudden drop in her blood pressure to 85/50 mmHg, with a concurrent increase in heart rate to 130 beats per minute, indicating potential hemodynamic instability. Her respiratory status worsens, with oxygen saturation declining to 88% on 6L nasal cannula. She now requires high-flow oxygen supplementation to maintain adequate oxygenation. Auscultation of her lungs reveals diminished breath sounds bilaterally, and she exhibits increased use of accessory muscles to breathe, suggesting further respiratory compromise.

A repeat laboratory evaluation shows a sharp decline in hemoglobin to 8.2 g/dL and platelet count dropping to 75,000/uL, exacerbating her pancytopenia. Her serum lactate climbs to 4.8 mmol/L, raising significant concern for lactic acidosis and worsening tissue perfusion. Additionally, her renal function deteriorates, with creatinine levels escalating from 1.1 mg/dL to 2.3 mg/dL, signifying acute kidney injury possibly from multifactorial causes including hypotension and sepsis.

The medical team, now facing the challenge of multi-organ dysfunction, swiftly initiates a norepinephrine infusion to support her blood pressure while closely monitoring her fluid balance due to the risk of exacerbating her pulmonary edema. A multidisciplinary consultation, including oncology, nephrology, and critical care specialists, is convened to reassess her treatment strategy, weighing the risks and benefits of further chemotherapy against the backdrop of her deteriorating clinical status. This critical juncture demands a nuanced approach, as the team must prioritize stabilization of her vital functions while considering the broader context of her advanced metastatic disease.

Section 4

As the team continues to navigate the complexity of the patient's condition, they observe a concerning development: the patient begins exhibiting signs of altered mental status, becoming increasingly lethargic and less responsive to verbal stimuli. This neurological change prompts an urgent reassessment, given the potential implications of central nervous system involvement or worsening systemic instability. A focused neurological examination reveals sluggish pupillary responses and a Glasgow Coma Scale score that has deteriorated to 10, underscoring the need for immediate intervention.

Concurrently, the team receives new diagnostic results from the latest imaging studies. A chest CT scan reveals bilateral pleural effusions, with a notable increase in size since the last imaging, likely contributing to her respiratory distress. Additionally, there is evidence of new metastatic lesions in the liver, which may be accounting for her deteriorating liver function tests, including elevated bilirubin and transaminases. The abdominal ultrasound further corroborates these findings, showing hepatomegaly and increased ascites, complicating her fluid management strategy.

In response to these developments, the medical team adjusts their approach, prioritizing the stabilization of her neurological status while addressing the underlying causes. An emergent thoracentesis is performed to relieve the pleural effusion and improve her respiratory function. The team also deliberates the initiation of alternative therapies, such as parenteral nutrition to support her nutritional status, given her gastrointestinal involvement and reduced oral intake. This situation necessitates a delicate balance, as the team strives to manage her acute symptoms without exacerbating her already fragile state, while also keeping an eye on the potential need for palliative care discussions, considering the progression of her metastatic disease.

Section 5

As the team closely monitors the patient following the thoracentesis, they observe a temporary improvement in her respiratory status, with oxygen saturation levels increasing to 92% on 4L nasal cannula. However, within hours, there is a new complication: the patient develops acute confusion and agitation, despite the earlier improvement in her Glasgow Coma Scale score. Repeat neurological assessments reveal that her pupillary responses have become unequal, with the right pupil showing sluggish reaction compared to the left, raising concerns for possible intracranial pathology. The team orders an urgent CT scan of the head, which reveals multiple small brain metastases with evidence of surrounding edema, likely contributing to her altered mental status.

Lab results further complicate the situation. Her liver function tests indicate worsening hepatic impairment, with bilirubin levels now peaking at 5.2 mg/dL, AST at 190 U/L, and ALT at 165 U/L. Her coagulation profile is also concerning, with an elevated INR of 2.3, suggesting a coagulopathy that could be secondary to her liver dysfunction or paraneoplastic syndrome. The findings prompt an interdisciplinary discussion about the next steps, including consideration for corticosteroids to manage cerebral edema and potential anticoagulation therapy adjustments.

The team faces a critical juncture, weighing the risks and benefits of escalating treatment versus transitioning to a palliative approach. They engage in a collaborative decision-making process, incorporating input from oncology, neurology, and palliative care specialists, while also preparing to have a compassionate and honest conversation with the patient’s family about prognosis and goals of care. This case presents a profound opportunity for advanced clinical reasoning, as the team must synthesize complex data, anticipate potential complications, and navigate the ethical intricacies of managing a rapidly evolving clinical scenario.